A new Emory-led scientific review is putting extra weight on a familiar worry. Body fat is not just about how your clothes fit. Researchers estimate that roughly 10 percent of new cancer diagnoses each year are linked to overweight and obesity, and sustained weight loss of more than 10 percent may lower that risk. The analysis, led by Dr. Neil Iyengar, director of Emory’s Winship Cancer Institute, pulls together decades of lab and population research to show how excess adipose tissue can reshape growth signals and immunity.
The review, published March 9 in JAMA, reports that overweight and obesity are associated with about 10 percent of new cancer diagnoses each year in the United States and with as much as half of some cancers, including endometrial and hepatobiliary malignancies. By synthesizing mechanistic studies and large observational datasets, the authors outline how inflamed fat tissue can drive up estrogen production, oxidative stress and immune suppression, conditions that can make it easier for tumors to form and grow.
In Atlanta, Iyengar and Emory clinicians say those numbers should change what happens in exam rooms. As Iyengar told the Atlanta Journal-Constitution, “the more fat tissue (someone has) and the more obese a person is, the more profound the negative or harmful effects,” and the paper notes that the review warns high body-fat percentage can raise cancer risk even at a normal BMI. That local takeaway, clinic leaders say, means routine conversations about cancer risk need to include weight, body fat and metabolic markers alongside the usual screening talk.
Younger Adults See Steeper Cancer Increases
The review highlights that breast and other obesity-related cancers are rising faster in adults ages 25 to 49, according to the authors writing in JAMA. Adding to the concern, a March report from the American Cancer Society found that colorectal cancer has become the leading cause of cancer death for people younger than 50, a trend linked in part to increasing rates in younger adults and more diagnoses at late stages.
What Weight Loss Actually Does
Observational studies cited in the review found that patients who lost more than 10 percent of their body weight, whether through bariatric surgery or with glucagon-like peptide-1 (GLP-1) receptor agonists, had modest reductions in the incidence of obesity-associated cancers, although the absolute changes were small. Local experts caution, as reported by the Atlanta Journal-Constitution, that these results come mainly from observational data and that randomized trials are still needed to prove a causal cancer-prevention benefit for weight-loss drugs.
What To Ask Your Doctor In Atlanta
Doctors say patients should not wait for the topic to come up. At routine visits, they suggest asking about body-fat measurement, metabolic markers such as glucose and lipids, and whether earlier cancer screening might apply in your case. The American Cancer Society recommends that colorectal screening start at age 45 for adults at average risk, and local resources such as Emory’s Winship Cancer Institute can help connect patients with screening and weight-management programs, Winship Cancer Institute.
The researchers behind the review call for more clinical trials and public health investment to prevent obesity and to make long-term weight management widely available. For Atlanta residents, that translates into clearer discussions with primary care providers and better access to screening and evidence-based weight-loss support from centers across the region.
